EP13.03. Outcomes of ES-SCLC Patients Treated with Platinum Doublet and Immunotherapy: A Western Australia Retrospective Review - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Joann Lee
Meta Tag
Speaker Joann Lee
Topic SCLC & Neuroendocrine Tumors: First Line Therapy
extensive-stage small cell lung cancer
platinum-etoposide chemotherapy
real-world study
Australian population
overall survival
progression-free survival
objective response rate
duration of response
immune-related adverse events
Powered By